| Withdrawn | 3 | 0 | Europe | cyclosporine +mycophenolic acid+prednison, Triple therapy, Mycophenolic Acid + prednison, Conventional therapy | Hospital Universitario Fundación Alcorcón, Hospital Universitario 12 de Octubre, Hospital General Universitario Gregorio Marañon, Hospital Universitario Ramon y Cajal, Hospital Infanta Sofia, Hospital Universitario Infanta Leonor, Hospital Universitario Reina Sofia de Cordoba, Hospital Regional Universitario Carlos Haya, Hospital Universitario Virgen de la Victoria, University Hospital of the Nuestra Señora de Candelaria, Hospital Universitario de Guadalajara. Spain, Hospital San Pedro de Alcantara, Hospital Juan Canalejo | Lupus Nephritis | 03/14 | 10/14 | | |
NCT01762644 / 2015-000105-39: The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Omeprazole for Insulin Independence Among Recent Onset Type 1 Diabetes Patients |
|
|
| Withdrawn | 2b/3 | 0 | Europe, RoW | Oral Cyclosporine and Oral Omeprazole, Oral Omeprazole | Perle Bioscience, Inc., Syreon Corporation | Type 1 Diabetes | 05/16 | 08/16 | | |
| Completed | 2/3 | 130 | Canada, US | Rituximab, Rituxan, MabThera, Cyclosporine, Sandimmune | Mayo Clinic, Columbia University, University of British Columbia, Ohio State University, Stanford University, University of Washington, University of Michigan, University of Alabama at Birmingham, Case Western Reserve University, The Cleveland Clinic, University of Kansas Medical Center, University of Manchester, University Health Network, Toronto, University of Toronto, CHU de Quebec-Universite Laval, Washington University School of Medicine, Florida International University, University of Mississippi Medical Center, NYU Langone Health, Medical College of Wisconsin, University of Arizona, Sunnybrook Health Sciences Centre, Applied Health Research Centre, Fulk Family Foundation | Idiopathic Membranous Nephropathy | 10/17 | 10/17 | | |
